Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04338399
Title The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC (BURAN)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Adlai Nortye Biopharma Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS


No variant requirements are available.